Immunocore (IMCR)
(Delayed Data from NSDQ)
$35.29 USD
-0.64 (-1.78%)
Updated Oct 2, 2025 04:00 PM ET
After-Market: $34.93 -0.36 (-1.02%) 6:40 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Fundamental Charts
About Return on Equity (TTM)
Immunocore Holdings PLC Sponsored ADR's return on equity, or ROE, is -5.40% compared to the ROE of the Medical - Biomedical and Genetics industry of -65.07%. While this shows that IMCR has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
IMCR 35.29 -0.64(-1.78%)
Will IMCR be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for IMCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMCR
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y
IMCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues
MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
Other News for IMCR
IMCR falls 1.1% on October 1, leaving the technical picture intact
Crossed Above 20 Day Moving Average appears for IMCR after 5.79% move
Is IMCR positioned for a breakdown? 20 Day Moving Average Resistance shows up after climbing 0.94%
20 Day Moving Average Resistance appears for IMCR after 0.18% move
IMCR forms 50 Day Moving Average Support on September 25